Difference between revisions of "Part:BBa K3408010"
Line 31: | Line 31: | ||
①Take 2 bottles of 50 ml LB liquid medium with 10 μg/mL kanamycin, and inoculate the same amount of recombinant engineered bacteria. | ①Take 2 bottles of 50 ml LB liquid medium with 10 μg/mL kanamycin, and inoculate the same amount of recombinant engineered bacteria. | ||
− | ②After culturing engineered bacteria which have been transformed successfully for | + | ②After culturing engineered bacteria which have been transformed successfully for 12 hours, the test group is cultured in an anaerobic induced environment for 6 hours, and the negative control group is cultured in an aerobic environment for 6 hours. |
− | ③Measure | + | ③Measure OD<sub>600</sub> of bacteria liquid every 2 hours. |
Line 42: | Line 42: | ||
</html> | </html> | ||
− | Fig.2. Expected results: changes of | + | Fig.2. Expected results: changes of OD<sub>600</sub> over time |
These results are predicted because of the lack of experiment for the COVID-19. | These results are predicted because of the lack of experiment for the COVID-19. |
Revision as of 02:20, 28 October 2020
Pnar-B0034-Trigger RNA-B0015-PCⅠ-Switch RNA-mazF-B0015
We designed this composite part by combining Pnar, trigger RNA, PCⅠ, switch RNA and mazF. So we could utilize it to verify the feasibility of our device, which comprises of toehold switch and toxin — MazF.
Former composite part BBa_K3408006 has demonstrated the feasibility of Pnar, so when our engineered bacteria Bacillus subtilis is in anaerobic environment, Pnar is activated by global regulator—FNR. Then downstream trigger RNA is expressed. As switch RNA is constantly expressed under the control of PCⅠ, the trigger RNA can successfully trigger the toehold switch, thus leading to the expression of mazF. So Bacillus subtilis can commit suicide. When in aerobic environment, Pnar ceases to work, toehold switch cannot be triggered. As a result, mazF can not be expressed. This device proves that our suicide module and toehold switch can successfully combine together.
1. Experimental methods
1.1.Construction of the expression vector
The pWB980-DB is digested with enzyme EcoRI and PstI. The target fragment of the promoter, RBS, gene of phytase and terminator of this device are synthesized by the biotechnology company with 6×His tags added. Add EcoRI and PstI restriction sites to both ends of the target fragment respectively. Connect the target fragment to the plasmid vector to construct the expression vector Pnar-trigger RNA-PCⅠ-switch RNA-mazF.
Plasmid profile
Fig.1. The expression vector of device Pnar-trigger RNA-PCⅠ-switch RNA-mazF
1.2.Construction and screening of recombinant engineered bacteria
Using Bacillus subtilis WB800N as the expression host, the secretion expression vector pWB980-DB was transformed by electro-transformation. Inoculate them on LB solid medium coated with 10 μg/mL kanamycin, and incubate them overnight at 37 °C. Send transformants to biotechnology company for sequencing.
1.3. Characterization experiment
①Take 2 bottles of 50 ml LB liquid medium with 10 μg/mL kanamycin, and inoculate the same amount of recombinant engineered bacteria.
②After culturing engineered bacteria which have been transformed successfully for 12 hours, the test group is cultured in an anaerobic induced environment for 6 hours, and the negative control group is cultured in an aerobic environment for 6 hours.
③Measure OD600 of bacteria liquid every 2 hours.
2. Expected results
Fig.2. Expected results: changes of OD600 over time
These results are predicted because of the lack of experiment for the COVID-19.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 187
Illegal BglII site found at 409 - 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]